Category Archives: U.S. Policy and Funding

Leadership of Senate Foreign Relations introduces “PEPFAR Stewardship and Oversight Act of 2013”

By on .

With the introduction of the PEPFAR Stewardship and Oversight Act of 2013 Senators Robert Menendez and Bob Corker launched a bill Tuesday that both tweaks and extends the authorities of the 2003 legislation that started the United States President’s Emergency Plan For AIDS Relief. With House Foreign Affairs Committee leaders Reps. Ed Royce and Eliot […]

Report: Large gaps between “health rich” and “health poor,” mean big odds against children

By on .

If you have easy access to health information, education, technologies, medicine and care to prevent illness, as well as to treatment when you do get sick, you are health rich. If all of those are out of your reach, you are health poor. And if you are health poor, your chances of surviving childhood are […]

Report: Economic cost of flatlining HIV, TB, Malaria funds? Millions of lives, billions of dollars. Return on increased investments? Priceless . . .

By on .

Now is the time to step up investments, says report, which pegs costs of stalled HIV prevention at $47 billion, of undiagnosed TB at a million unnecessary deaths, and of malaria prevention and treatment failures at $20 billion lost productivity . . . Citing a need for an estimated $87 billion to countries eligible for […]

Report, patent reform add signposts to intersection of health and human rights

By on .

“It is well understood,” this paper from Yale’s Global Health Justice Partnership begins, “that patent protection increases the price of medicines and thereby decreases access to them.” The result: The rich really are different. They can have more health. It is a truth, this paper points out, that runs counter to the right to health […]